Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Receives $69.00 Consensus PT from Brokerages

Oncternal Therapeutics, Inc. (NASDAQ:ONCT – Get Free Report) has been assigned an average rating of “Hold” from the six brokerages that are presently covering the firm, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12-month price objective […]

Related Keywords

,Millennium Management ,Pasadena Private Wealth ,Oncternal Therapeutics Inc ,Nasdaq ,Vanguard Group Inc ,Healthcare Of Ontario Pension Plan Trust Fund ,Renaissance Technologies ,Oncternal Therapeutics ,Get Free Report ,Marketbeat Ratings ,Capital Management ,Ontario Pension Plan Trust Fund ,Get Free ,Orphan Receptor ,Oncternal Therapeutics Daily ,Nasdaq Onct ,Conct ,Medical ,Ratings ,Consensus ,